Skip to content

NovoCure Ltd

NVCR

CIK 0001645113 · Surgical & Medical Instruments & Apparatus · Nasdaq

← back to feed
Revenue (TTM)
$655.06M
+8.3% YoY Q1 Apr 2026
Net Income (TTM)
−$182.87M
+19.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.62
+21.8% YoY Q1 Apr 2026
Gross Margin
75.0%
Q1 Apr 2026
Operating Margin
-27.6%
Q1 Apr 2026
Net Margin
-27.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$71.45M
Q1 Apr 2026
Cash
$87.53M
Q1 Apr 2026
Total Debt
$195.05M
Q1 Apr 2026
Shares Outstanding
115.82M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings